1
|
Maggen C, Linssen J, Gziri MM, Zola P, Cardonick E, de Groot CJM, Garcia AC, Fruscio R, Drochytek V, Van Calsteren K, Albersen M, Amant F. Renal and Bladder Cancer During Pregnancy: A Review of 47 Cases and Literature-based Recommendations for Management. Urology 2020; 151:118-128. [PMID: 33203520 DOI: 10.1016/j.urology.2020.08.084] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 07/23/2020] [Accepted: 08/10/2020] [Indexed: 11/17/2022]
Abstract
OBJECTIVE To provide contemporary gestational age-specific recommendations for management, a retrospective series of patients with renal or bladder cancer during pregnancy is reported. METHODS Obstetric and oncological data of pregnant patients with a diagnosis of renal or bladder cancer were selected from the worldwide registry of the International Network of Cancer, Infertility and Pregnancy. In addition, the literature was reviewed for recent case reports since last reviews in 2014 for renal cancer and 2004 for bladder cancer. RESULTS International Network of Cancer, Infertility and Pregnancy registered 22 cases (14 renal cancer and 8 bladder cancer), diagnosed between 1999 and 2017, and the literature reported 15 cases with renal cancer and 10 cases with bladder cancer between 2004 and 2019. Most common symptoms for renal and bladder cancer were pain (28%) and hematuria (66%), respectively. In more than half of the patients, surgical treatment was performed during pregnancy. Preterm deliveries were mostly medically induced (12 of 17, 71%) and all patients with a planned delivery before 34 weeks had advanced cancer. For renal and bladder cancer respectively, 79% and 87% of patients obtained complete remission. Advanced cancer stages had worse prognosis; 3 of 7 patients with known follow-up deceased within 15 months after diagnosis. CONCLUSION Gestational age at diagnosis determines further management of renal and bladder cancers during pregnancy. Advanced stages challenge decision-making. The maternal needs for immediate treatment, and the neonatal risks including the impact of a preterm delivery should be discussed in a multidisciplinary setting while respecting the patient's autonomy.
Collapse
Affiliation(s)
- Charlotte Maggen
- Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium
| | - Jasmijn Linssen
- Department of Gynecological Oncology, Amsterdam University Medical Centres, Amsterdam, The Netherlands
| | - Mina Mhallem Gziri
- Department of Obstetrics, Cliniques Universitaires St Luc, UCL, Sint-Lambrechts-Woluwe, Belgium
| | - Paolo Zola
- Department Surgical Sciences, University of Torino, Torino, Italy
| | - Elyce Cardonick
- Department of Obstetrics and Gynecology, Cooper, University Health Care, Camden, New Jersey, USA
| | - Christianne J M de Groot
- Department of Obstetrics and Gynecology, and Amsterdam Reproduction and Development, Amsterdam University Medical Centers, Amsterdam, the Netherlands
| | - Alvaro Cabrera Garcia
- Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI) " Reference clinic for hemato-oncological diseases during pregnancy CREHER" Estado de México, México
| | - Robert Fruscio
- Clinic of Obstetrics and Gynecology, University of Milan - Bicocca, San Gerardo Hospital, Monza, Italy
| | - Vit Drochytek
- Faculty Hospital Kralovske, Vinohrady and 3rd Medical Faculty, Charles University, Prague, Czech Republic
| | - Kristel Van Calsteren
- Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium; Department of Development and Regeneration, KU Leuven, Leuven, Belgium
| | - Maarten Albersen
- Department of Urology, University Hospitals Leuven, Leuven, Belgium
| | - Frédéric Amant
- Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium; Department of Gynecological Oncology, Amsterdam University Medical Centres, Amsterdam, The Netherlands; Department of Gynecological Oncology, Amsterdam University Medical Centres, Amsterdam, The Netherlands and the Department of Gynecology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands.
| |
Collapse
|
2
|
Ohyama T, Shimbo M, Endo F, Kyono Y, Akitani F, Hayashi T, Komatsu K, Matsushita K, Suzuki K, Hattori K. Renal cell carcinoma treatment during pregnancy: Histopathological findings suggestive of rapid tumor growth. IJU Case Rep 2019; 2:265-268. [PMID: 32743433 PMCID: PMC7292109 DOI: 10.1002/iju5.12098] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2019] [Accepted: 05/30/2019] [Indexed: 01/19/2023] Open
Abstract
Introduction Diagnosis of renal cell carcinoma during pregnancy is rare. We report a case of renal cell carcinoma during pregnancy with rapid growth. Case presentation A 39‐year‐old woman presented to our hospital for treatment of renal tumor at 22 weeks gestation. The tumor had a cystic lesion with a partition and showed rapid growth from 28 mm to 32 mm over a period of 4 weeks. The tumor was diagnosed as renal cell carcinoma and an open partial nephrectomy was scheduled at 26 weeks gestation. The operation and perioperative course were successful. Pathological findings confirmed the tumor to be clear cell renal cell carcinoma with G2 > G3, Fuhrman grade 2, pT1a, negative surgical margin, and positive detection of progesterone receptor. Conclusion We reported the successful management of a patient who was diagnosed with renal cell carcinoma during pregnancy. We also had a suggested association between rapid growth tumor and progesterone based on histopathological analysis of the tumor.
Collapse
Affiliation(s)
- Takehiro Ohyama
- Department of Urology St. Luke's International Hospital Tokyo Japan
| | - Masaki Shimbo
- Department of Urology St. Luke's International Hospital Tokyo Japan
| | - Fumiyasu Endo
- Department of Urology St. Luke's International Hospital Tokyo Japan
| | - Yoko Kyono
- Department of Urology St. Luke's International Hospital Tokyo Japan
| | - Fumi Akitani
- Department of Gynecology St. Luke's International Hospital Tokyo Japan
| | - Tokuhito Hayashi
- Department of Anesthesiology St. Luke's International Hospital Tokyo Japan
| | - Kenji Komatsu
- Department of Urology St. Luke's International Hospital Tokyo Japan
| | | | - Kosuke Suzuki
- Department of Pathology St. Luke's International Hospital Tokyo Japan
| | - Kazunori Hattori
- Department of Urology St. Luke's International Hospital Tokyo Japan
| |
Collapse
|
3
|
Majos M, Majos A, Polguj M, Szymczyk K, Chrostowski J, Stefańczyk L. Diameters of Arteries Supplying Horseshoe Kidneys and the Level They Branch off Their Parental Vessels: A CT-Angiographic Study. J Clin Med 2019; 8:jcm8040464. [PMID: 30959826 PMCID: PMC6518850 DOI: 10.3390/jcm8040464] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Revised: 03/21/2019] [Accepted: 03/29/2019] [Indexed: 02/07/2023] Open
Abstract
Background: The most common renal fusion anomaly is horseshoe kidney (HSK), a condition associated with variable arterial blood supply. The aim of this study was to determine whether the height of origin of the renal artery determines its diameter and whether it differs from the mean diameter of the renal arteries of normal kidneys (NK). Methods: Computer tomography angiography (CTA) studies of 336 patients (88 HSK and 248 NK) were obtained in a search of renal arteries; these were than classified into four groups according to height of its origin: Group I, branching from the aorta superior to the inferior mesenteric artery (IMA); Group II, branching from the aorta below the IMA; Group III, branching from the iliac artery; and Group IV, originating from the internal and external iliac artery. Results: The HSK group included 398 arteries (mean diameter 4.30 mm) and the NK group 598 (5.52 mm) (p < 0.0001). In the HSK group, the mean diameters according to groups were: Group I, 4.54 mm; Group II, 4.28 mm; Group III, 3.41 mm; and Group IV, 3.43 mm. Statistically significant differences were found between arteries originating from the aorta and arteries branching from the iliac arteries (p < 0.0001). In the NK group, the corresponding values were: Group I, 5.53 mm; and Group II, 4.45 mm. The number of arteries supplying the HSK wider than 3.0 mm were: Group I, 83.0%; Group II, 82.4%; Group III, 68.4%; and Group IV, 66.6%. Conclusions: The renal arteries of the HSK branch from their parental vessels at lower levels and have smaller diameters than those of NK.
Collapse
Affiliation(s)
- Marcin Majos
- Department of Radiology, Barlicki University Hospital, Medical University of Łódź, Kopcińskiego Str. 22, 90-153 Łódź, Poland.
| | - Agata Majos
- Department of Radiological and Isotopic Diagnosis and Therapy, Medical University of Łódź, ul. Pomorska 251, 92-213 Łódź, Poland.
| | - Michał Polguj
- Department of Angiology, Interfaculty Chair of Anatomy and Histology, Medical University of Łódź, Żeligowskiego 7/9, 90-752 Łódź, Poland.
| | - Konrad Szymczyk
- Department of Radiology, Barlicki University Hospital, Medical University of Łódź, Kopcińskiego Str. 22, 90-153 Łódź, Poland.
| | - Jakub Chrostowski
- Department of Radiological and Isotopic Diagnosis and Therapy, Medical University of Łódź, ul. Pomorska 251, 92-213 Łódź, Poland.
| | - Ludomir Stefańczyk
- Department of Radiology, Barlicki University Hospital, Medical University of Łódź, Kopcińskiego Str. 22, 90-153 Łódź, Poland.
| |
Collapse
|
4
|
Yilmaz E, Oguz F, Tuncay G, Melekoglu R, Beytur A, Inci Coskun E, Gunes A. Renal cell carcinoma diagnosed during pregnancy: a case report and literature review. J Int Med Res 2018; 46:3422-3426. [PMID: 29882451 PMCID: PMC6134677 DOI: 10.1177/0300060518776744] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Diagnosing cancer during pregnancy is uncommon. Although pregnancies with concomitant malignancies have been reported, urological tumours are possibly the most rarely identified tumours during pregnancy. Renal cell carcinoma appears to be the most common urological malignancy during pregnancy. In this case report, we discuss successful management of a patient who was diagnosed with renal cell carcinoma during the antenatal period.
Collapse
Affiliation(s)
- Ercan Yilmaz
- 1 Department of Obstetrics and Gynecology, Faculty of Medicine, Inonu University, Malatya, Turkey
| | - Fatih Oguz
- 2 Department of Urology, Faculty of Medicine, Inonu University, Malatya, Turkey
| | - Gorkem Tuncay
- 1 Department of Obstetrics and Gynecology, Faculty of Medicine, Inonu University, Malatya, Turkey
| | - Rauf Melekoglu
- 1 Department of Obstetrics and Gynecology, Faculty of Medicine, Inonu University, Malatya, Turkey
| | - Ali Beytur
- 2 Department of Urology, Faculty of Medicine, Inonu University, Malatya, Turkey
| | - Ebru Inci Coskun
- 1 Department of Obstetrics and Gynecology, Faculty of Medicine, Inonu University, Malatya, Turkey
| | - Ali Gunes
- 2 Department of Urology, Faculty of Medicine, Inonu University, Malatya, Turkey
| |
Collapse
|
5
|
Chys B, Dumont S, Van Calsteren K, Albersen M, Joniau S. Renal Neoplasm During Pregnancy: A Single Center Experience. Clin Genitourin Cancer 2018; 16:e501-e507. [DOI: 10.1016/j.clgc.2018.02.018] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2018] [Accepted: 02/20/2018] [Indexed: 11/29/2022]
|
6
|
El-Ghawet HA, Gadallah AA, El-Mansi AA, Amin AH, El-Sayyad HIH. Markers of Heart, Lung and Dorsal Aorta Damage of Mother Rats and Their Neonates Post Therapeutic Treatment with Doxorubicin, Cisplatin and 5-Flurouracil. Chin Med 2017. [DOI: 10.4236/cm.2017.83007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|